Coronavirus Disease 2019 Severity in Patients with Adenocarcinoma of the Left Lung: A Case Report
M N Pradhan
Keywords :
Coronavirus disease 2019, Intensive care unit, Lung cancer, Mortality
Citation Information :
Pradhan MN. Coronavirus Disease 2019 Severity in Patients with Adenocarcinoma of the Left Lung: A Case Report. Indian J Respir Care 2023; 12 (2):185-187.
Patients with cancer are the most vulnerable population against coronavirus disease 2019 (COVID-19), as they need continuous medical care and regular contact with hospital environments, which put them at risk of COVID-19 disease. We describe a case of a 62-year-old male patient presented with severe COVID-19 who is being admitted to our intensive care unit (ICU) and diagnosed with adenocarcinoma of the posterobasal segment in the left lower lobe of the lung. For lung cancer (Ca lung) patients, refined and individualized management is needed during the COVID-19 epidemic to maximize benefits.
Mohapatra P, Bhuniya S, Panigrahi M, et al. P09.48 experience and outcome of COVID-19-positive lung cancer patients from a Eastern Indian hospital. J Thorac Oncol 2021;16(3):S311–S312. DOI: 10.1016/j.jtho.2021.01.476
Wang Q, Berger NA, Xu R. Analyses of risk, racial disparity, and outcomes among us patients with cancer and COVID-19 infection. JAMA Oncol 2021;7(2):220–227. DOI: 10.1001/jamaoncol.2020.6178
Desai A, Sachdeva S, Parekh T, et al. COVID-19 and cancer: lessons from a pooled meta-analysis. J Glob Oncol 2020;6:557–559. DOI: 10.1200/GO.20.00097
Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov 2020;10(6):783–791. DOI: 10.1158/2159-8290.CD-20-0422
Tian J, Yuan X, Xiao J, et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol 2020;21(7):893–903. DOI: 10.1016/S1470-2045(20)30309-0
Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21(3):335–337. DOI: 10.1016/S1470-2045(20)30096-6
Conti P, Ronconi G, Caraffa A, et al. Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVID-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents 2020;34(2):327–331. DOI: 10.23812/CONTI-E
Luo P, Liu Y, Qiu L, et al. Tocilizumab treatment in COVID-19: a single-center experience. J Med Virol 2020;92(7):814–818. DOI: 10.1002/jmv.25801
COVID-19 provider and practice information. Available from: https://www.asco.org/asco-coronavirus-information/provider-practice-preparedness-covid-19. [Last accessed on 2 Feb 2021].
ASCO special report: a guide to cancer care delivery during the COVID-19 pandemic. Available from: https://www.asco.org/sites/new-www.asco.org/files/content-files/2020-ASCO-Guide-. ASCO special report: a guide to cancer care delivery during the COVID-19 pandemic. Available from: https://www.asco.org/sites/new-www.asco.org/files/content-files/2020-ASCO-Guide-Cancer-COVID19.pdf. [Last accessed on 2 Feb 2021].
Grant WB, Garland CF. The association of solar ultraviolet B (UVB) with reducing the risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res 2006;26(4A):2687–2699. PMID: 16886679.
